Literature DB >> 12524378

Granulocyte colony-stimulating factor enhances alpha-naphthylthiourea-induced pulmonary hypertension.

Elie Azoulay1, Saadia Eddahibi, Elisabeth Marcos, Micheline Levame, Alain Harf, Benoit Schlemmer, Serge Adnot, Christophe Delclaux.   

Abstract

Physiopathological discrepancies exist between the most widely used models of pulmonary hypertension (PH), namely monocrotaline- and hypoxia-induced PH. The development of a new model could help in the understanding of underlying mechanisms. Repeated alpha-naphthylthiourea (ANTU) injections (5 mg/kg weekly, 3 wk) induced pulmonary vascular remodeling, which was associated with development of PH and right ventricular hypertrophy. ANTU followed by granulocyte colony-stimulating factor (G-CSF; 25 microgram. kg(-1). day(-1) subcutaneously, 3 days/wk) induced higher pulmonary arterial pressures and right ventricular hypertrophy than ANTU alone. Lidocaine, which inhibits neutrophil functions, inhibited PH exacerbation by G-CSF. Endothelial nitric oxide synthase expression, measured to assess ANTU-related endothelial toxicity, decreased significantly in ANTU-treated rats and fell even more sharply when G-CSF was given. This occurred despite a significant increase in vascular endothelial cell growth factor expression in lung and right ventricle in rats given ANTU alone and even more in rats given ANTU plus G-CSF. Repeated ANTU administration induces PH with vascular remodeling that can be further aggravated by the neutrophil activator G-CSF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524378     DOI: 10.1152/japplphysiol.00807.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  3 in total

1.  IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13.

Authors:  Min-Jong Kang; Je-Min Choi; Bo Hye Kim; Chang-Min Lee; Won-Kyung Cho; Gina Choe; Do-Hyun Kim; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2012-03-01       Impact factor: 21.405

Review 2.  Vascular repair and regeneration as a therapeutic target for pulmonary arterial hypertension.

Authors:  Laszlo Farkas; Martin Kolb
Journal:  Respiration       Date:  2013-03-22       Impact factor: 3.580

3.  Effects of bevacizumab administration on the hypoxia-induced pulmonary hypertension rat model.

Authors:  Canan Demir; Meral Karaman; Eyüp Sabri Uçan; Ali Necati Gökmen; Duygu Gürel; Şadiye Canan Çoker; Yasemen Adali; Osman Yilmaz
Journal:  Turk J Med Sci       Date:  2021-08-02       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.